Extended release pharmaceutical formulation

Patent

Open access

United States Patent and Trademark Office

11/04/2019

Handle:

https://hdl.handle.net/10523/46546

Abstract

The invention provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.

url

Link to patent information (PATENTSCOPE)View

6 Record Views

Record Identifier: 9926746379301891
Title: Extended release pharmaceutical formulation
Creators: Natalie Hughes
Paul Glue
Peter Surman
Contributors: Douglas Pharmaceuticals Ltd. (Assignee)
Academic Unit: Psychological Medicine (DSM); School of Pharmacy
Publisher: United States Patent and Trademark Office
Patent number; date issued; agency; status: US 10,441,544; United States Patent and Trademark Office (United States, Alexandria) - USPTO
Application number; date: 15728695; 10/10/2017
Date published ; e-published: 11/04/2019
Language: English
Resource Type ; Subtype: Patent